Chong Kun Dang Pharmaceutical Corp. (KOSE:A185750) announces a share repurchase program. Under the program, the company will repurchase up to KRW 10,000 million worth of its shares pursuant to a contract with KB Securities Co.

Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on February 10, 2023. As of February 9, 2022, the company had 204,884 shares in treasury within the scope available for dividend and 47,773 shares in treasury through other repurchases.